United States - English - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - meclizine hydrochloride (unii: hdp7w44cio) (meclizine - unii:3l5tq84570) - management of nausea and vomiting, and dizziness associated with motion sickness. meclizine hcl, usp is contraindicated in individuals who have shown a previous hypersensitivity to it.

United States - English - NLM (National Library of Medicine)

honeywell safety products usa, inc - water (unii: 059qf0ko0r) (water - unii:059qf0ko0r) - eyewash - for flushing the eye to remove loose foreign material, air pollutants or chlorinated water first aid antiseptic - first aid to help prevent the risk of infection in minor cuts, scrapes, and burns first aid antibiotic - first aid to help prevent infection in - minor cuts - scrapes - burns first aid antiseptic - first aid to help prevent infection in minor cuts, scrapes and burns benzethonium chloride 0.2% w/w benzocaine 10% w/w menthol 0.33% w/w for the temporary relief of pain and itching and helps protect against infection in: - minor cuts and scrapes - burns - sunburn - insect bites - minor skin irritations anti-itch cream - for the temporary relief of itching associated with minor skin irritations and rashes

United States - English - NLM (National Library of Medicine)

beiersdorf inc. - avobenzone (unii: g63qqf2nox) (avobenzone - unii:g63qqf2nox), octisalate (unii: 4x49y0596w) (octisalate - unii:4x49y0596w), octocrylene (unii: 5a68wgf6wm) (octocrylene - unii:5a68wgf6wm), homosalate (unii: v06sv4m95s) (homosalate - unii:v06sv4m95s) - sunscreen ■ helps prevent sunburn ■ if used as directed with other sun protection measures (see directions ), decreases the risk of skin cancer and early skin aging caused by the sun

United States - English - NLM (National Library of Medicine)

merck sharp & dohme llc - interferon alfa-2b (unii: 43k1w2t1m6) (interferon alfa-2b - unii:43k1w2t1m6) - interferon alfa-2b 38 ug in 1 ml - intron® a is indicated for the treatment of patients 18 years of age or older with hairy cell leukemia. intron a is indicated as adjuvant to surgical treatment in patients 18 years of age or older with malignant melanoma who are free of disease but at high risk for systemic recurrence, within 56 days of surgery. intron a is indicated for the initial treatment of clinically aggressive (see clinical pharmacology ) follicular non-hodgkin's lymphoma in conjunction with anthracycline-containing combination chemotherapy in patients 18 years of age or older. efficacy of intron a therapy in patients with low-grade, low-tumor burden follicular non-hodgkin's lymphoma has not been demonstrated. intron a is indicated for intralesional treatment of selected patients 18 years of age or older with condylomata acuminata involving external surfaces of the genital and perianal areas (see dosage and administration ). the use of this product in adolescents has not been studied. intron a is indicated for the treatment of select

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - bumetanide (unii: 0y2s3xuq5h) (bumetanide - unii:0y2s3xuq5h) - bumetanide 0.5 mg - bumetanide tablets usp are indicated for the treatment of edema associated with congestive heart failure, hepatic and renal disease, including the nephrotic syndrome. almost equal diuretic response occurs after oral and parenteral administration of bumetanide. therefore, if impaired gastrointestinal absorption is suspected or oral administration is not practical, bumetanide should be given by the intramuscular or intravenous route. successful treatment with bumetanide tablets usp following instances of allergic reactions to furosemide suggests a lack of cross-sensitivity. bumetanide is contraindicated in anuria. although bumetanide can be used to induce diuresis in renal insufficiency, any marked increase in blood urea nitrogen or creatinine, or the development of oliguria during therapy of patients with progressive renal disease, is an indication for discontinuation of treatment with bumetanide. bumetanide is also contraindicated in patients in hepatic coma or in states of severe electrolyte depletion until

United States - English - NLM (National Library of Medicine)

rite aid corporation - calamine 8% and zinc oxide 8% - skin protectant dries the oozing and weeping o poison ivy, poison oak, and poison sumac.

United States - English - NLM (National Library of Medicine)

cardinal health - racepinephrine hydrochloride (unii: 336096p2we) (racepinephrine - unii:gr0l9s3j0f) - bronchodilator for temporary relief of mild symptoms of intermittent asthma:

United States - English - NLM (National Library of Medicine)

elanco us inc. - cyclosporine (unii: 83hn0gtj6d) (cyclosporine - unii:83hn0gtj6d) - cyclosporine 10 mg - atopica is indicated for the control of atopic dermatitis in dogs weighing at least 4 lbs. (1.8 kg) body weight. atopica is contraindicated for use in dogs with a history of neoplasia. do not use in dogs with a hypersensitivity to cyclosporine.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

farmalinx pty ltd - ammonium thiocyanate; amitrole - soluble concentrate - ammonium thiocyanate cyanide active 220.0 g/l; amitrole triazole active 250.0 g/l - herbicide - aquatic areas weed control - see label | building | commercial/industrial land | domestic and/or public area | drain | dry drain - african daisy | apple-of-sodom | artichoke thistle | blackberry | broadleaf weeds and grasses | capeweed | chilean cestrum | clover | common reed or phragmites | couch | creeping/russian knapweed,hardhead | cumbungi | dock | fennel | furze or gorse | heliotrope - heliotropium spp. | hoary cress or whiteweed | illyrian thistle | khaki weed | kikuyu grass | mouse-ear chickweed | nutgrass | onion weed | oxalis spp. | ox-eye daisy | paterson's curse | prairie ground cherry | ryegrass | sand brome | silvergrass - vulpia spp. | sorrel | sowthistle - seedling | spear thistle - seedling | tree pear | water couch | water hyacinth | watsonia | wild oat | winter grass | yorkshire fog grass | acetosella vulgaris | alternanthera repens | annual blue grass | annual poa | asphodel | australian brome | black thistle seedling | blackberry with st john's wort | broadleaf cumbungi | broadleaf dock | bullrush | bulrush | cardoon | cat's tail | curled dock | echium lycopsis | echium spp. | fog grass | goose grass | green cestrum

Australia - English - Department of Health (Therapeutic Goods Administration)

ausmedic australia pty ltd - 58060 - virtual-display arm rehabilitation system, non-gravity-compensating - an assembly of devices designed to provide non-gravity-compensating therapy for a patient who has lost motor function of the arm(s) caused by cerebral, neurogenic, spinal, muscular or bone-related disorders through interaction with a computer program prompting repeated motion of the arms, fingers, and hands to improve grip strength, range of motion, and train fine and gross motor tasks that mimic activities of daily living. it consists of a joystick, visual display unit (vdu), and computer-calculated arm/finger position and training program. it is used for inpatients, outpatients or home settings for patients able to understand and interact with the audio-visual instructions..